Dr. Lodewick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 La Casa Via
Ste 209
Walnut Creek, CA 94598Phone+1 925-930-6252Fax+1 925-930-0942
Education & Training
- University of WashingtonFellowship, Allergy and Immunology, 2001 - 2003
- University of WashingtonResidency, Pediatrics, 1998 - 2001
- University of Alabama School of MedicineClass of 1998
Certifications & Licensure
- OR State Medical License 2003 - Present
- CA State Medical License 2004 - 2026
- WA State Medical License 2000 - 2005
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
- National Board of Physicians and Surgeons Allergy and Immunology
- National Board of Physicians and Surgeons Pediatrics
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FAAP) American Academy of Pediatrics
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsAsthma economics: focusing on therapies that improve costly outcomes.Karna Gendo, Matthew Lodewick
Current Opinion in Pulmonary Medicine. 2005-01-01 - 2 citationsFood Sublingual Immunotherapy Using Consistent, Cheaper and Customizable Oral Immunotherapy Solutions.Karna Gendo, Tony Orden, Allyson Tevrizian, Joshua J. Jacobs, Nancy Mozelsio
Journal of Asthma and Allergy. 2021-05-05 - Oral immunotherapy using weight by volume solutions.Karna Gendo, Tony Orden, Allyson Tevrizian, Joshua Jacobs, Nancy Mozelsio
Journal of Food Allergy. 2020-12-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: